WHO Foundation and L’Oréal Partner to Advance Global Skin Health The WHO Foundation and L’Oréal Group, through its Dermatological Beauty division, have announced a landmark four-year partnership aimed at improving global access to skin health treatments. This initiative is particularly…
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company dedicated to advancing the field of minimally invasive surgery, has announced a key leadership transition. Effective April 25, 2025, Randy Clark, the current…
Ant Group has announced significant upgrades to its full-suite AI solutions for the healthcare sector, reinforcing its commitment to supporting hospitals, doctors, and users through cutting-edge artificial intelligence. These advancements aim to enhance operational efficiency, improve patient care, and offer…
Omnicell Appoints Perry A. Genova, PhD, as Chief Technology Officer Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming pharmacy and nursing care delivery, has announced the appointment of Perry A. Genova, PhD, as Senior Vice President…
Byondis Appoints Christoph Korpus, PhD, MBA, as Chief Business Officer Byondis BV, an independent biopharmaceutical company dedicated to developing innovative, targeted medicines for cancer patients, has announced the appointment of Christoph Korpus, PhD, MBA, as its new Chief Business Officer…
Amplar Health and Australian Government Collaborate to Transform Aged Care with Virtual Nursing Amplar Health has announced a groundbreaking partnership with the Australian Government to introduce an innovative virtual nursing model aimed at supporting the aged care sector. This collaboration…
People-Powered, Tech-Enabled Pharmacy Experience A Tech-Enabled, People-Powered Pharmacy Experience Digital First, Not Digital Only In today’s rapidly evolving healthcare landscape, technology plays a crucial role in enhancing pharmacy care. Digital tools provide accessibility, personalization, and convenience, improving the overall experience…
Omeros Updates Zaltenibart Phase 3 PNH Trial Omeros Corporation (Nasdaq: OMER) has announced significant progress in its Phase 3 clinical trial program for zaltenibart (OMS906), an investigational inhibitor of MASP-3, the key and most proximal activator of the alternative pathway…
VantAI Unveils Neo-1: AI Model for Molecular Interaction Design VantAI has unveiled Neo-1, the world’s most advanced atomistic foundation model, marking a significant milestone in molecular design and drug discovery. Announced at NVIDIA GTC 2025, Neo-1 is the first AI…
FDA Inspection Seminar: Preparation & Survival Guide (On-Demand) ResearchAndMarkets.com has expanded its offerings with the addition of the “FDA Inspection Seminar: How to Prepare for and Survive an Inspection.” This on-demand training is designed to equip professionals across pharmaceutical, biopharmaceutical,…
Enigma Biomedical USA Selects 4R Tau PET Biomarker Candidate Enigma Biomedical USA, Inc. (EB USA) has announced the selection of two four-repeat tau (4R Tau) protein PET imaging biomarkers to advance into Phase 1 (Ph1) studies. This milestone follows EB…
Almirall’s 16th Skin Academy Unites Experts to Advance Dermatology Almirall, a global pharmaceutical company specializing in medical dermatology, is hosting the 16th edition of its prestigious Skin Academy. This annual event serves as a premier conference for healthcare professionals in…